Search research articles
Contact Us
Filters
Showing results (1-10 of 255) with videos related to
Page
of 26
Sort By:
Blood Purification
|
December 15, 2015
Current Focuses in Serum Lipid Abnormalities in Dialysis Patients
Tetsuo Shoji
Clinical and Experimental Nephrology
|
September 28, 2013
Serum lipids and prevention of atherosclerotic cardiovascular events in hemodialysis patients
Tetsuo Shoji
Clinical Calcium
|
January 13, 2011
[Benefit of vitamin D receptor activation in CKD]
Tetsuo Shoji
Nihon Jinzo Gakkai Shi
|
December 3, 2013
[Clinical practice guidelines for the management of dyslipidemia in chronic kidney disease]
Tetsuo Shoji
Clinical Calcium
|
July 4, 2012
[Kidney and bone update : the 5-year history and future of CKD-MBD. Progress in therapy of CKD-MBD with vitamin D receptor activators]
Tetsuo Shoji
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
|
June 15, 2012
[Chronic kidney disease (CKD)--recent progress. Topics: VI. Chronic kidney disease (CKD) and associated disorders; 4. Dyslipidemia in chronic kidney disease]
Tetsuo Shoji
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
|
November 24, 2015
[Kidney diseases and metabolic disorders--Basics and applications required for general physicians. Topics: III. Abnormalities in lipid metabolism in chronic kidney disease]
Tetsuo Shoji
Journal of Atherosclerosis and Thrombosis
|
March 4, 2026
Two-Step Clinical Pathways to Cardiovascular Mortality in Chronic Kidney Disease and Dialysis -- A Narrative Review
Tetsuo Shoji, Christoph Wanner
Clinical Calcium
|
May 2, 2007
[Effects of vitamin D on non-classical target organs and survival]
Tetsuo Shoji, Yoshiki Nishizawa
Nature Clinical Practice. Nephrology
|
August 26, 2006
Does paricalcitol reduce proteinuria in patients with chronic kidney disease?
Yoshiki Nishizawa, Tetsuo Shoji
Page
of 26
Search research articles
Search
Showing results (1-10 of 255) with videos related to
Sort By:
Page
of 26
Blood Purification
|
December 15, 2015
Current Focuses in Serum Lipid Abnormalities in Dialysis Patients
Tetsuo Shoji
Clinical and Experimental Nephrology
|
September 28, 2013
Serum lipids and prevention of atherosclerotic cardiovascular events in hemodialysis patients
Tetsuo Shoji
Clinical Calcium
|
January 13, 2011
[Benefit of vitamin D receptor activation in CKD]
Tetsuo Shoji
Nihon Jinzo Gakkai Shi
|
December 3, 2013
[Clinical practice guidelines for the management of dyslipidemia in chronic kidney disease]
Tetsuo Shoji
Clinical Calcium
|
July 4, 2012
[Kidney and bone update : the 5-year history and future of CKD-MBD. Progress in therapy of CKD-MBD with vitamin D receptor activators]
Tetsuo Shoji
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
|
June 15, 2012
[Chronic kidney disease (CKD)--recent progress. Topics: VI. Chronic kidney disease (CKD) and associated disorders; 4. Dyslipidemia in chronic kidney disease]
Tetsuo Shoji
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
|
November 24, 2015
[Kidney diseases and metabolic disorders--Basics and applications required for general physicians. Topics: III. Abnormalities in lipid metabolism in chronic kidney disease]
Tetsuo Shoji
Journal of Atherosclerosis and Thrombosis
|
March 4, 2026
Two-Step Clinical Pathways to Cardiovascular Mortality in Chronic Kidney Disease and Dialysis -- A Narrative Review
Tetsuo Shoji, Christoph Wanner
Clinical Calcium
|
May 2, 2007
[Effects of vitamin D on non-classical target organs and survival]
Tetsuo Shoji, Yoshiki Nishizawa
Nature Clinical Practice. Nephrology
|
August 26, 2006
Does paricalcitol reduce proteinuria in patients with chronic kidney disease?
Yoshiki Nishizawa, Tetsuo Shoji
Page
of 26